NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD.
Ip CT, Ganz M, Dam VH, Ozenne B, Rüesch A, Köhler-Forsberg K, Jørgensen MB, Frokjaer VG, Søgaard B, Christensen SR, Knudsen GM, Olbrich S.
Ip CT, et al.
J Psychiatr Res. 2021 Sep;141:57-65. doi: 10.1016/j.jpsychires.2021.06.021. Epub 2021 Jun 18.
J Psychiatr Res. 2021.
PMID: 34175743
Free article.